Halifax
Canada
24
2023-05-04
The entities that hold a legal rights for patent applications filed by inventor Mansour Marc:
Marc Mansour from Halifax, CA has applied for patents for these inventions. The list has both pending applications and granted patents:
NOVEL SALMONELLA-BASED CORONAVIRUS VACCINE
#2 | 2022-11-03Methods of using low dose volume B-cell epitope compositions for inducing an antibody immune response in human subjects
#3 | 2022-01-06ADJUVANTING SYSTEMS AND WATER-FREE VACCINE COMPOSITIONS COMPRISING A POLYI:C POLYNUCLEOTIDE ADJUVANT AND A LIPID-BASED ADJUVANT
#4 | 2021-10-21USE OF LIPOSOMES IN A CARRIER COMPRISING A CONTINUOUS HYDROPHOBIC PHASE FOR DELIVERY OF POLYNUCLEOTIDES IN VIVO
#5 | 2021-10-07LIPOSOME COMPOSITIONS COMPRISING PAM2CYS OR PAM3CYS ADJUVANT AND METHODS FOR INDUCING A HUMORAL IMMUNE RESPONSE
#6 | 2021-02-25METHOD FOR IMPROVING THE EFFICACY OF A SURVIVIN VACCINE IN THE TREATMENT OF CANCER
#7 | 2020-04-09Lipid A mimics, methods of preparation, and uses thereof
#8 | 2019-09-26Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance
#9 | 2019-07-25Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of polynucleotides in vivo
#10 | 2019-07-25Methods of using low dose volume B-cell epitope compositions for inducing an antibody immune response in human subjects
#11 | 2019-05-16Liposome compositions comprising PAM2Cys or PAM3Cys adjuvant and methods for inducing a humoral immune response
#12 | 2018-11-29Adjuvanting systems and water-free vaccine compositions comprising a polyI:C polynucleotide adjuvant and a lipid-based adjuvant
#13 | 2018-10-11Method for improving the efficacy of a survivin vaccine in the treatment of cancer
#14 | 2018-06-28Use of liposomes in a carrier comprising a continuous hydrophobic phase as a vehicle for cancer treatment
#15 | 2018-01-11Lipid A mimics, methods of preparation, and uses thereof
#16 | 2017-02-02Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of polynucleotides in vivo
#17 | 2016-03-10Method for improving the efficacy of a survivin vaccine in the treatment of cancer
#18 | 2015-07-23Use of liposomes in a carrier comprising a continuous hydrophobic phase as a vehicle for cancer treatment
#19 | 2014-08-21Liposome compositions comprising an adjuvant that activates or increases the activity of TLR2 and uses thereof
#20 | 2011-03-24Compositions Comprising Liposomes, An Antigen, A Polynucleotide and A Carrier Comprising a Continuous Phase of a Hydrophobic Substance
#21 | 2010-08-19COMPOSITIONS COMPRISING AN ANTIGEN, AN AMPHIPATHIC COMPOUND AND A HYDROPHOBIC CARRIER, AND USES THEREOF
#22 | 2010-08-12Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of polynucleotides in vivo
#23 | 2009-12-03Use of Liposomes in a Carrier Comprising a Continuous Hydrophobic Phase as a Vehicle for Cancer Treatment
#24 | 2006-06-06Antigens for immunocontraception
879292 ⎘